Chimera Investment Corp (CIM) concluded trading on Thursday at a closing price of $14.34, with 0.45 million shares of worth about $6.4 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.65% during that period and on July 03, 2025 the price saw a gain of about 0.70%. Currently the company’s common shares owned by public are about 80.97M shares, out of which, 78.47M shares are available for trading.
Stock saw a price change of 1.77% in past 5 days and over the past one month there was a price change of 7.42%. Year-to-date (YTD), CIM shares are showing a performance of 14.63% which increased to 2.43% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $9.85 but also hit the highest price of $16.89 during that period. The average intraday trading volume for Chimera Investment Corp shares is 615.25K. The stock is currently trading 3.13% above its 20-day simple moving average (SMA20), while that difference is up 8.10% for SMA50 and it goes to 1.85% higher than SMA200.
Chimera Investment Corp (NYSE: CIM) currently have 80.97M outstanding shares and institutions hold larger chunk of about 57.17% of that.
The stock has a current market capitalization of $1.16B and its 3Y-monthly beta is at 1.85. PE ratio of stock for trailing 12 months is 9.61, while it has posted earnings per share of $1.49 in the same period. Its PEG reads 0.86 and has Quick Ratio of 0.10 while making debt-to-equity ratio of 3.93. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CIM, volatility over the week remained 2.16% while standing at 1.92% over the month.
Stock’s fiscal year EPS is expected to rise by 25.27% while it is estimated to increase by 2.68% in next year. EPS is likely to grow at an annualized rate of 11.21% for next 5-years, compared to annual growth of -27.34% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on May 14, 2025 offering a Buy rating for the stock and assigned a target price of $15 to it. Coverage by UBS stated Chimera Investment Corp (CIM) stock as a Neutral in their note to investors on December 06, 2023, suggesting a price target of $5.50 for the stock. Stock get a Neutral rating from Credit Suisse on August 21, 2019.
